Celesio Investors Hold Back Support For $5.5B McKesson Bid
California drugmaker McKesson Inc. said Monday that investors in German rival Celesio AG will have another two weeks to back its takeover play after they have so far proven slow to...To view the full article, register now.
Already a subscriber? Click here to view full article